Artículo

Machine Learning in Drug Discovery and Development Part 1: A Primer

Talevi, Alan Icon; Morales, Juan Francisco Icon; Hather, Gregory ; Podichetty, Jagdeep T. ; Kim, Sarah ; Bloomingdale, Peter C. ; Kim, Samuel ; Burton, Jackson ; Brown, Joshua D. ; Winterstein, Almut G. ; Schmidt, Stephan ; White, Jensen Kael ; Conrado, Daniela J.

Otros responsables

Fecha

03/2020

Editorial

American Society for Clinical Pharmacology and Therapeutics

Revista

CPT: Pharmacometrics and Systems Pharmacology

Título del libro

Nombre del evento

Fecha del evento

Institución organizadora

ISSN

2163-8306

eISSN

ISBN

Idioma

Inglés

Tipo del evento

Resumen

Artificial intelligence, in particular machine learning (ML), has emerged as a key promising pillar to overcome the high failure rate in drug development. Here, we present a primer on the ML algorithms most commonly used in drug discovery and development. We also list possible data sources, describe good practices for ML model development and validation, and share a reproducible example. A companion article will summarize applications of ML in drug discovery, drug development, and postapproval phase.

Aprobación

Revisión

Complementado por

Referenciado por

Licencia Creative Commons

Excepto donde se indique lo contrario, la licencia de este ítem se describe como by-nc